---
category: news
title: "Relief Therapeutics Holding (RLF:SIX) Drug Aviptadil Enters FDA Trial at NYU Langone Health, New York, to Treat COVID-19-Induced Acute Respiratory Distress"
excerpt: "Relief Therapeutics Holding drug Aviptadil enters FDA trial at NYU Langone Health, New York, to treat COVID-19-ARDS"
publishedDateTime: 2020-05-06T05:30:00Z
webUrl: "https://www.businesswire.com/news/home/20200505006171/en/Relief-Therapeutics-Holding-RLFSIX-Drug-Aviptadil-Enters"
type: article
quality: 13
heat: 13
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - Coronavirus in US
  - Coronavirus

tags:
  - US-NY

images:
  - url: "https://mms.businesswire.com/media/20200505006171/en/789663/23/logo_Relief_small.jpg"
    width: 1200
    height: 627
    title: "Relief Therapeutics Holding (RLF:SIX) Drug Aviptadil Enters FDA Trial at NYU Langone Health, New York, to Treat COVID-19-Induced Acute Respiratory Distress"

secured: "tUY4e7iJ5Cz2bEQnztyfzCPFP9gra5rGU2lVw/mS1Z42pF9Al7DRgYWXg3VN02lnPcOhECuRNlLqaVP6H5cW/BrtaCNOKLz4wNH2vas9KYdguC7XpFEiidW/j8u+4cXIR/5eXsVIHkuPkm1zvg/M7KV0SW6YSzsc+o3rzpwVELlxpg07OQ0joflAqeB5m7O08An6xr0M54axR6ZVJ63kllt2Orz9TFKNJyfwYSneBz/FSflmU6+3ZqC48iE/OuMC1No+VT9Ly8vql3rBA3j/eMTHtgHZXZ/SUNELTfqXlfks/72FtMg8oFklJx9yZTuY;83PKVGN/e0KJmeRffIBZ3A=="
---

